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Recent genetic studies have led to identification of numerous loci that are associated with susceptibility to autoimmune
diseases. The strategy of using information from these studies has facilitated the identification of novel juvenile idiopathic
arthritis (JIA) susceptibility loci, specifically, PTPN22 and IL2RA. Several novel autoimmune susceptibility loci have recently
been identified, and we hypothesise that single-nucleotide polymorphisms (SNPs) within these genes may also be JIA
susceptibility loci. Five SNPs within the genes AFF3, IL2/IL21, IL7R, CTLA4 and CD226, previously associated with multiple
autoimmune diseases were genotyped, in a large data set of Caucasian JIA patients and controls, and tested for association
with JIA. We identified two susceptibility loci for JIA, AFF3 and the IL2/IL21 region and additional weak evidence supporting an
association with the CTLA4 and IL7R genes, which warrant further investigation. All results require validation in independent
JIA data sets. Further characterisation of the specific causal variants will be required before functional studies can
be performed.
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Keywords: autoimmune; juvenile idiopathic arthritis; CTLA4; AFF3; IL2
Introduction
Autoimmune diseases are caused by dysregulation of the
immune system leading to an immune response to self-
tissue. Autoimmune diseases are complex genetic dis-
eases and in the last few years great progress has been
made in the search for susceptibility loci.
1,2 As more
confirmed autoimmune disease susceptibility loci are
identified, an interesting story is emerging in that many
of these loci predispose to more than one autoimmune
disease. This confirms the hypothesis that shared alleles
contribute to a spectrum of diseases and suggests that
common immunological pathways are involved in
susceptibility to these phenotypically distinct diseases.
3
Juvenile idiopathic arthritis (JIA) is another complex
genetic autoimmune disease characterised by chronic
inflammatory disease in children. It is a group of
heterogeneous disorders but encompasses all forms of
arthritis of unknown aetiology that starts before the age
of 16 and which persists for at least 6 weeks.
4 The
strategy of using information from autoimmune disease
genome-wide association studies or candidate gene
studies have facilitated the search for novel JIA suscept-
ibility loci. Indeed two recently identified confirmed JIA
susceptibility loci, PTPN22
5 and IL2RA
6 are putative
autoimmune susceptibility genes as they also show
association with rheumatoid arthritis (RA),
5,7 type I
diabetes (T1D)
7,8 and Graves’ disease.
9,10 In addition,
using a strategy of examining confirmed RA suscept-
ibility loci in JIA, we have recently reported evidence for
association of two further loci (TRAF1/C5 and STAT4)
with JIA susceptibility.
11
Several novel putative autoimmune susceptibility loci
have recently been identified with association with
multiple autoimmune diseases. These include the IL2/21
region on chromosome 4q23
12,13 and the genes encoding
IL7R,
14–16 CTLA4,
17 AFF3
14 and CD226.
18 We hypothesise
that these genes may also confer susceptibility to JIA
and, therefore, the aim of this study was to determine
whether single-nucleotide polymorphisms (SNPs) within
these genes are also associated with susceptibility to JIA.
Results and discussion
In this study, using a strategy of examining previously
associated autoimmune loci in JIA, we have identified
association of two loci with JIA susceptibility (Table 1).
First, we show association of a SNP (rs1160542) in the 50
region of the AFF3 gene (Table 1), a gene that is
preferentially expressed in lymphoid cells and has a
potential regulatory role in lymphoid development.
19
This SNP has been associated with RA
20 and a perfect
proxy SNP (r
2¼1), rs9653442 has been associated with
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14 with similar odds ratio and allele frequencies to
that observed in this study of JIA.
Second, we found strong association of a SNP
(rs6822844) mapping within the IL2–IL21 locus on
chromosome 4q27, which has previously been associated
with RA, T1D and coeliac disease (Table 1).
12,13 The SNP
lies approximately 24kb 50 of the IL21 gene. The SNP lies
within a block of high linkage disequilibrium, which
contains four genes, KIAA1109, TENR, IL2 and IL21.A s
for the other diseases, it is the common allele, which
predisposes to JIA. This association confirms a recently
published association of the IL2_IL2 region with JIA
susceptibility.
21 We performed a meta-analysis of the two
studies, which yielded highly significant evidence for
association (odds ratio 0.77 95% confidence interval 0.69–
0.87, P¼1 10
 5) with no evidence for heterogeneity
between the two cohorts (P¼0.81). This finding is
interesting in light of the previous confirmed association
of the IL2RA gene with JIA
6 and may suggest that the IL2
pathway is particularly important in JIA susceptibility.
We found a weak trend toward association of a SNP in
the IL7R gene with JIA (Table 1), in line with the previous
association of this SNP with RA, T1D
14 and multiple
sclerosis
15,16 the common allele of the SNP was increased
in cases compared with controls, although this did not
achieve statistical significance. However, this study was
under-powered with only 18% power to detect an effect
(Supplementary Table 2). Therefore, additional indepen-
dent studies and meta-analyses of this SNP will be
required to confirm it as associated with JIA suscept-
ibility. The SNP is a non-synonymous SNP within exon 6
of IL7R and has a functional effect on gene expression,
resulting in altered ratios of soluble and membrane-
bound isoforms of the protein.
15
SNPs within the CTLA4 gene, previously associated
with T1D and autoimmune thyroid disease
17 have
previously been examined in JIA with conflicting
results.
22,23 This may reflect true genetic heterogeneity
at this locus or may be due to the modest sample sizes
used in previous investigations. We found a weak
association of the CTLA4 CT60 SNP (rs3087243) with
UK JIA cases (Table 1), although this study only had 53%
power to detect an effect (Supplementary Table 2).
However, no evidence for association of this SNP with
JIA was detected in a recent large study of US JIA
families and controls.
23 We used the Cochran–Mantel–
Haenszel test to perform a meta-analysis combining data
from this study and the Prahalad study; this yielded
weak but statistically significant evidence for association
(odds ratio 0.92 95% confidence interval 0.84–1.0,
P¼0.05) with no evidence for heterogeneity (by Bre-
slow–Day test) between the two cohorts (P¼0.44).
Further analysis of this SNP in independent data sets
followed by meta-analysis will be essential to robustly
determine whether CTLA4 represents a JIA susceptibility
locus. It is obviously a good candidate as an autoimmune
susceptibility locus because of its role as a negative
regulator of T-cell activation.
17 Furthermore, the CT60
SNP is found within the 30 untranslated region, in which
the G allele is associated with susceptibility to several
autoimmune diseases and also has a functional effect of
lower mRNA levels of the soluble CTLA4 isoform.
17
Finally, a non-synonymous SNP, rs763361, in exon 7 of
the CD226 gene has recently been associated with
multiple autoimmune diseases including T1D, multiple
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RA.
18 In our total JIA analysis, we found no significant
association of the SNP with JIA (Table 1). However, we
only had 24% power to detect an effect (Supplementary
Table 2).
Figure 1 shows a comparison between the association
analysis results in T1D, RA, multiple sclerosis and JIA.
For all the SNPs tested, the same allele was associated
with JIA as was associated with the other autoimmune
diseases and effect sizes are similar. Hence, the failure
to confirm association with CTLA4 and IL7R at the
corrected threshold could be due to a lack of statistical
power (53 and 18%, respectively) (Supplementary
Table 2). It has not always been the case for the
overlapping autoimmune disease susceptibility loci, that
the same allele is associated. For example in PTPN22, the
minor allele of the R620W SNP is associated with greater
risk of developing RA, JIA, T1D and SLE but is protective
for Crohn’s disease.
24,25 There is also emerging data
suggesting that one of the associated SNPs at the IL2RA
locus confers differing risk and protective effects for T1D
and multiple sclerosis.
26,27
JIA is a phenotypically heterogeneous disease and can
be classified into more clinically homogeneous diseases
using the ILAR classification criteria (Supplementary
Table 1).
28 However, comparing each of the ILAR
subtypes separately against controls would result in a
large number of hypothesis tests. Therefore, we first
examined whether there was evidence of a difference in
allele frequencies between the seven ILAR subtypes.
Differences between subtypes were assessed using w
2
tests on the 7 2 tables. Only when a difference was
found (Po0.05) were separate odds ratios and 95%
confidence intervals calculated for the subgroups. In all
cases, this was not significant (P40.05) (data not shown).
Therefore, further stratification by ILAR subtype was not
performed. Larger sample sizes will be required to fully
examine subgroup differences.
In conclusion, adopting the strategy of targeting loci
with previous evidence for association in multiple
autoimmune diseases has identified two novel JIA loci,
AFF3 and the IL2/IL21 locus.
Conflict of interest
The authors declare no conflict of interest.
Acknowledgements
This work was supported by the Arthritis Research
Campaign: arc grant reference no: 17552. We thank
David Strachan for facilitating access to the 1958 birth
cohort. We acknowledge use of genotype data from the
British 1958 Birth Cohort DNA collection, funded by the
Medical Research Council grant G0000934 and the
Wellcome Trust grant 068545/Z/02.
References
1 Lettre G, Rioux JD. Autoimmune diseases: insights from
genome-wide association studies. Hum Mol Genet 2008; 17
(R2): R116–R121.
2 Zhernakova A, van Diemen CC, Wijmenga C. Detecting
shared pathogenesis from the shared genetics of immune-
related diseases. Nat Rev Genet 2009; 10: 43–55.
3 Vyse TJ, Todd JA. Genetic analysis of autoimmune disease.
Cell 1996; 85: 311–318.
4 Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet 2007;
369: 767–778.
5 Hinks A, Worthington J, Thomson W. The association of
PTPN22 with rheumatoid arthritis and juvenile idiopathic
arthritis. Rheumatology (Oxford) 2006; 45: 365–368.
6 Hinks A, Ke X, Barton A, Eyre S, Bowes J, Worthington J et al.
Association of the IL2RA/CD25 gene with juvenile idiopathic
arthritis. Arthritis Rheum 2009; 60: 251–257.
7 The Wellcome Trust Case Control Consortium. Genome-wide
association study of 14000 cases of seven common diseases
and 3000 shared controls. Nature 2007; 447: 661–678.
8 Lowe CE, Cooper JD, Brusko T, Walker NM, Smyth DJ, Bailey
R et al. Large-scale genetic fine mapping and genotype-
phenotype associations implicate polymorphism in the IL2RA
region in type 1 diabetes. Nat Genet 2007; 39: 1074–1082.
9 Brand OJ, Lowe CE, Heward JM, Franklyn JA, Cooper JD,
Todd JA et al. Association of the interleukin-2 receptor alpha
(IL-2Ralpha)/CD25 gene region with Graves’ disease using
a multilocus test and tag SNPs. Clin Endocrinol (Oxf) 2007; 66:
508–512.
10 Smyth D, Cooper JD, Collins JE, Heward JM, Franklyn JA,
Howson JM et al. Replication of an association between the
lymphoid tyrosine phosphatase locus (LYP/PTPN22) with
type 1 diabetes, and evidence for its role as a general
autoimmunity locus. Diabetes 2004; 53: 3020–3023.
11 Hinks A, Eyre S, Ke X, Barton A, Martin P, Flynn E et al.
Overlap of disease susceptibility loci for rheumatoid arthritis
(RA) and juvenile idiopathic arthritis (JIA). Ann Rheum Dis
2009; e-pub ahead of print 11 August 2009.
12 van Heel DA, Franke L, Hunt KA, Gwilliam R, Zhernakova A,
Inouye M et al. A genome-wide association study for celiac
disease identifies risk variants in the region harboring IL2 and
IL21. Nat Genet 2007; 39: 827–829.
13 Zhernakova A, Alizadeh BZ, Bevova M, van Leeuwen MA,
Coenen MJ, Franke B et al. Novel association in chromosome
4q27 region with rheumatoid arthritis and confirmation of
type 1 diabetes point to a general risk locus for autoimmune
diseases. Am J Hum Genet 2007; 81: 1284–1288.
14 Todd JA, Walker NM, Cooper JD, Smyth DJ, Downes K,
Plagnol V et al. Robust associations of four new chromosome
regions from genome-wide analyses of type 1 diabetes.
Nat Genet 2007; 39: 857–864.
15 Gregory SG, Schmidt S, Seth P, Oksenberg JR, Hart J, Prokop A
et al. Interleukin 7 receptor alpha chain (IL7R) shows allelic
Figure 1 Plot of odds ratios for minor allele for SNPs previously
associated with autoimmune disease, comparison with JIA. Plots of
odds ratios and 95% confidence intervals for the association analysis
of all SNPs, results in T1D (black dots and lines), in RA (blue dots
and lines), in JIA (red dots and lines) and in MS (green dots and
lines). References
12,14,16–18 and Barton (2009) submitted.
Association of the AFF3 gene and IL2/IL21 gene region with JIA
A Hinks et al
196
Genes and Immunityand functional association with multiple sclerosis. Nat Genet
2007; 39: 1083–1091.
16 Lundmark F, Duvefelt K, Iacobaeus E, Kockum I, Wallstrom E,
Khademi M et al. Variation in interleukin 7 receptor alpha
chain (IL7R) influences risk of multiple sclerosis. Nat Genet
2007; 39: 1108–1113.
17 Ueda H, Howson JM, Esposito L, Heward J, Snook H,
Chamberlain G et al. Association of the T-cell regulatory gene
CTLA4 with susceptibility to autoimmune disease. Nature
2003; 423: 506–511.
18 Hafler JP, Maier LM, Cooper JD, Plagnol V, Hinks A,
Simmonds MJ et al. CD226 Gly307Ser association with multi-
ple autoimmune diseases. Genes Immun 2008; 10: 5–10.
19 Ma C, Staudt LM. LAF-4 encodes a lymphoid nuclear protein
with transactivation potential that is homologous to AF-4,
the gene fused to MLL in t(4;11) leukemias. Blood 1996; 87:
734–745.
20 Barton A, Eyre S, Ke X, Hinks A, Bowes J, Flynn E et al.
Identification of AF4/FMR2 family, member 3 (AFF3) as a
novel rheumatoid arthritis susceptibility locus and confirma-
tion of two further pan-autoimmune susceptibility genes.
Hum Mol Genet 2009; 18: 2518–2522.
21 Albers HM, Kurreeman FA, Stoeken-Rijsbergen G, Brinkman
DM, Kamphuis SS, Van Rossum MA et al. Association of the
autoimmunity locus 4q27 with juvenile idiopathic arthritis.
Arthritis Rheum 2009; 60: 901–904.
22 Suppiah V, O’doherty C, Heggarty S, Patterson CC, Rooney M,
Vandenbroeck K. The CTLA4+49A/G and CT60 polymorph-
isms and chronic inflammatory arthropathies in Northern
Ireland. Exp Mol Pathol 2006; 80: 141–146.
23 Prahalad S, Bohnsack JF, Whiting A, Clifford B, Jorde LB,
Guthery SL et al. Lack of association of functional CTLA4
polymorphisms with juvenile idiopathic arthritis. Arthritis
Rheum 2008; 58: 2147–2152.
24 Vang T, Congia M, Macis MD, Musumeci L, Orru V,
Zavattari P et al. Autoimmune-associated lymphoid tyrosine
phosphatase is a gain-of-function variant. Nat Genet 2005; 37:
1317–1319.
25 Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux
JD et al. Genome-wide association defines more than 30
distinct susceptibility loci for Crohn’s disease. Nat Genet 2008;
40: 955–962.
26 Maier LM, Lowe CE, Cooper J, Downes K, Anderson DE,
Severson C et al. IL2RA genetic heterogeneity in multiple
sclerosis and type 1 diabetes susceptibility and soluble inter-
leukin-2 receptor production. PLoS Genet 2009; 5: e1000322.
27 Alcina A, Fedetz M, Ndagire D, Fernandez O, Leyva L,
Guerrero M et al. IL2RA/CD25 gene polymorphisms: uneven
association with multiple sclerosis (MS) and type 1 diabetes
(T1D). PLoS ONE 2009; 4: e4137.
28 Petty RE, Southwood TR, Manners P, Baum J, Glass DN,
Goldenberg J et al. International league of associations for
rheumatology classification of juvenile idiopathic arthritis:
second revision, Edmonton, 2001. J Rheumatol 2004; 31: 390–392.
29 Packham JC, Hall MA. Long-term follow-up of 246 adults
with juvenile idiopathic arthritis: functional outcome. Rheu-
matology (Oxford) 2002; 41: 1428–1435.
30 Adib N, Hyrich K, Thornton J, Lunt M, Davidson J, Gardner-
Medwin J et al. Association between duration of symptoms
and severity of disease at first presentation to paediatric
rheumatology: results from the childhood arthritis prospective
study. Rheumatology (Oxford) 2008; 47: 991–995.
31 Thomson W, Barton A, Ke X, Eyre S, Hinks A, Bowes J et al.
Rheumatoid arthritis association at 6q23. Nat Genet 2007; 39:
1431–1433.
32 Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA,
Bender D et al. PLINK: a tool set for whole-genome association
and population-based linkage analyses. Am J Hum Genet 2007;
81: 559–575.
This work is licensed under the Creative
Commons Attribution-NonCommercial-No
Derivative Works 3.0 Licence. To view a copy of this
licence, visit http://creativecommons.org/licenses/by-nc-
nd/3.0/
Appendix
Childhood Arthritis Prospective Study (CAPS): Arc Epide-
miology Unit, University of Manchester—Kimme Hyr-
ich, Mark Lay, Sham Lal, Paul Gilbert, Peter Ward;
Alderhey—Eileen Baildam, Carol Lydon, Lynsey Brown;
Glasgow—Joyce Davidson, Janet Gardner-Medwin, Vicki
Price, Jane Sim, Maureen Todd; Great Ormond Street—
Lucy Wedderburn, Alexandra Meijer, Julie Jones; New-
castle—Helen Foster, Mark Friswell, Michael Eltringham;
Manchester—Alice Chieng, Joanne Buckley; Other—
Tauny Southwood
UKRAG Consortium: University of Manchester
1:
Stephen Eyre, Anne Hinks, Laura J Gibbons, John Bowes,
Edward Flynn, Paul Martin, Xiayi Ke, Rachelle Donn,
Wendy Thomson, Anne Barton, Jane Worthington
University of Leeds
2: YEAR Consortiumw, Stephen
Martin, James I Robinson, Ann W Morgan, Paul Emery
University of Sheffield
3: Anthony G Wilson
University of London
4: Sophia Steer
University of Aberdeen
5: Lynne Hocking, David M
Reid
University of Oxford
6: Pille Harrison, Paul
Wordsworth
1arc-Epidemiology Unit, Stopford Building, The
University of Manchester, Manchester, UK
2Leeds Institute of Molecular Medicine, Section of
Musculoskeletal Disease, University of Leeds, Leeds
LS9 7TF, UK
3School of Medicine & Biomedical Sciences, The
University of Sheffield, Sheffield S10 2JF, UK
4Clinical and Academic Rheumatology, Kings College
Hospital NHS Foundation Trust, Denmark Hill,
London SE5 9RS, UK
5Bone Research Group, Department of Medicine &
Therapeutics, University of Aberdeen, Aberdeen AB25
2ZD, UK
6University of Oxford Institute of Musculoskeletal
Sciences, Botnar Research Centre, Oxford OX3 7LD, UK
YEAR Consortium: Management Team—Professor Paul
Emery
1, Professor Philip Conaghan
1, Dr Mark Quinn
2,D r
Ann W Morgan
1, Dr Anne-Maree Keenan
1, Dr Elizabeth
Hensor
1, Julie Kitcheman
1. Consultants—Dr Andrew
Gough
3, Dr Michael Green
2,3, Dr Richard Reece
4,D r
Lesley Hordon
5, Dr Philip Helliwell1
6, Dr Richard
Melsom
6, Dr Sheelagh Doherty
7, Dr Ade Adebajo
8,D r
Andrew Harvey
9, Dr Steve Jarrett
9, Dr Gareth Huson
1,D r
Amanda Isdale
2, Dr Mike Martin
1, Dr Zunaid Karim
9,
Prof Dennis McGonag1e
10, Dr Colin Pease
1, Dr Sally
Cox
1. SpRs—Dr Victoria Bejarano
1, Dr Jackie Nam
1.
Nurses—Claire Brown
1, Christine Thomas
1, David
Pickles
1, Alison Hammond
1, Beverley Neville
3, Alan
Association of the AFF3 gene and IL2/IL21 gene region with JIA
A Hinks et al
197
Genes and ImmunityFairclough
4, Caroline Nunns
4, Anne Gill
2, Julie Green
2,
Belinda Rhys-Evans
1, Barbara Padwell
1, Julie Madden
10,
Lynda Taylor
10, Sally Smith
1, Heather King
1, Jill Firth
6,
Jayne Heard
7, Linda Sigsworth
6. Lab Staff—Diane Cors-
cadden
1, Karen Henshaw
1, Lubna-Haroon Rashid
1, Ste-
phen G Martin
1, James I Robinson
1
1Section of Musculoskeletal Disease, LIMM, Leeds, UK
2York District Hospital, York, UK
3Harrogate District Hospital, Harrogate, UK
4Huddersfield Royal Infirmary, Huddersfield, UK
5Dewsbury District and General Hospital, Dewsbury, UK
6St Luke’s Hospital, Bradford, UK
7Hull Royal Infirmary, Hull, UK
8Barnsley District General Hospital, Barnsley, UK
9Pinderfields General Hospital, Wakefield, UK
10Calderdale Royal Hospital, Halifax, UK
British Society of Paediatric and Adolescent Rheumatology
(BSPAR) study group: M Abinum, MD, M Becker, MD, A
Bell, MD, A Craft, MD, E Crawley, MD, J David, MD, H
Foster, MD, J Gardener-Medwin, MD, J Griffin, MD, A
Hall, MD, M Hall, MD, A Herrick, MD, P Hollingworth,
MD, L Holt, MD, S Jones, MD, G Pountain, MD, C Ryder,
MD, T Southwood, MD, I Stewart, MD, H Venning, L
Wedderburn, MD, P Woo, MD and S Wyatt, MD.
Supplementary Information accompanies the paper on Genes and Immunity website (http://www.nature.com/gene)
Association of the AFF3 gene and IL2/IL21 gene region with JIA
A Hinks et al
198
Genes and Immunity